Pan African Bioinformatics Network for H3Africa

The H3AbioNet Scientific Advisory Board (SAB)

A team of independent experts was invited to form the SAB. The SAB provides regular valuable feedback and advice to the H3ABioNet consortium, the board members are described below.


Board Members 

Dr Adebowale Adeyemo

 Adeyemo March2013

Deputy Director, Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA: Dr Adeyemo studies the genetic epidemiology of complex diseases (hypertension, obesity, diabetes and related traits) and the genomics of populations of African ancestry. His research applies tools from the disciplines of genetic epidemiology, statistical genetics, bioinformatics and molecular genetics. A graduate of medicine of the University of Ibadan and a trained pediatrician, he has held academic and/or research posts at the University of Ibadan, and at the National Human Genome Center at Howard University, Washington DC. Dr Adeyemo has authored or co-authored over 180 papers in peer-reviewed journals. He is first author on the papers describing: the first genome wide association study (GWAS) for hypertension and blood pressure among African Americans, the first genome scan for obesity in an African publication, the first genome wide linkage analysis for serum lipids in an African population and the first study of genetic structure in West Africans using genome wide markers. Dr Adeyemo has served on grant review panels for the NIH (USA), the Wellcome Trust (UK), National Research Foundation of South Africa, and Foundation for Science and Technology of Portugal. He serves on the advisory panel of several projects/centers and is currently co-chair of the H3Africa Genome Analysis Working Group.

Dr Ayo Oduola

 Coming soon! 

Professor David Roos


E. Otis Kendall Professor of Biology, University of Pennsylvania: Professor Roos' research integrates diverse disciplines, ranging from molecular genetics and cell biology, to biochemistry and pharmacology, to computer science and genomics, to immunology and international public health. Current interests focus on protozoan parasites, including Toxoplasma (a prominent congenital pathogen and opportunistic infection associated with AIDS), and Plasmodium (the causative agent of malaria). Work in the Roos lab has yielded genetic tools for the molecular dissection of parasite pathogenesis and drug resistance mechanisms, new insights into the function and evolution of subcellular organelles (including novel therapeutic targets), and computational resources designed to ensure that genomic-scale datasets are readily accessible to researchers worldwide. Dr. Roos also directs the Eukaryotic Pathogen Genome Database (EuPathDB.org), an on-line resource used daily by many thousands of researchers.

Professor B.F. Francis Ouellette


Associate Director, Informatics and Biocomputing, OICR: Francis Ouellette is a Senior Scientist and Associate director of the Informatics and Biocomputing platform at the Ontario Institute for Cancer Research (OICR). At the OICR Francis oversees the evaluation and development of pipelines for the analysis of next generation sequencing cancer genomic and transcriptomic data. He also oversees the curation of the International Cancer Genome Consortium data, and is involved in the oversight of many aspects and working groups at the ICGC (see http://icgc.org). Francis is also the scientific coordinator and instructor with the Canadian Bioinformatics Workshop series (see http://bioinformatics.ca) where they use the latest technologies and applications to train bioinformaticians. His research activities and interests include biological sequence analysis systems, genome annotation, and the analysis of cancer genomes. Francis is also an Associate Professor in the Cell and Systems Biology department at the University  of Toronto and Adjunct Professor, Department of Molecular Biology and  Biochemistry, Simon Fraser University, Burnaby BC. He serves on many advisory boards including Genome Canada's Science and Industry Advisory Council and on several NIH-funded projects, including: SGD, Galaxy, HMP2 and GenomeSpace.

Dr Jessica Kissinger


Director, Institute of Bioinformatics: Dr Kissinger received her undergraduate degree from the University of Chicago and her PhD. from Indiana University, Bloomington, in molecular and developmental biology with a minor in genetics.  She had post-doctoral positions in parasitology and bioinformatics at the National Institutes of Health, Bethesda, MD, USA, Centro de Pesquisas René Rachou – FIOCRUZ – Belo Horizonte, MG Brazil, and the University of Pennsylvania, Philadelphia, PA, USA.  She has been a faculty member at the University of Georgia’s Department of Genetics, Center for Tropical and Emerging Global Diseases and Institute of Bioinformatics since 2002. She is a member of ASTMH, the American Medical Informatics Association among others. She serves on several advisory boards for the National Institutes of Health including the Louisiana State University INBRE external advisory committee; the West African International Center of Excellence in Malaria Research in addition to the H3 Africa BioNet External Advisory Group.  She has a long history of global bioinformatics training via the WHO and other mechanisms. Currently she is Co-PI of the Eukaryotic Pathogens Resource Center (http://EuPathDB.org) and the Malaria Host-Pathogen Interaction Center (http://SystemsBiology.emory.edu)

Professor Mark McCarthy 


Robert Turner Professor of Diabetic Medicine at the University of Oxford: Mark's research team is based in Oxford and has a long-standing interest in the genetics of complex traits including type 2 diabetes, obesity and growth. The group has played a leading role in international efforts to apply genome wide association approaches to study these traits, work that has contributed to identification of over 50 genomic regions involved in susceptibility to type 2 diabetes, and a similar number impacting on other traits. They are now extending these studies to sequence-based discovery via the GoT2D and t2D-GENES consortia. This work has provided novel biological insights into the pathogenesis of these conditions and underpins future efforts to translate genetic findings into clinical practice.